肝硬化腹水合并低钠血症56例临床治疗研究

Clinical Study on 56 Cases of Cirrhosis Ascites Complicated with Hyponatremia

目的:探讨肝硬化腹水合并低钠血症的临床治疗方法和效果。方法:选取2017年3月-2018年3月笔者所在医院收治的56例肝硬化腹水合并低钠血症患者,随机把两组患者均分成研究组和对照组。对照组患者实施限钠治疗,研究组患者实施补钠治疗,对照两组患者的治疗总有效率、肝硬化腹水程度及并发症发生率情况的差异。结果:研究组患者的治疗总有效率明显高于对照组,肝硬化腹水程度明显低于对照组,且并发症发生率低于对照组,差异均有统计学意义(P<0.05)。结论:肝硬化腹水合并低钠血症易出现多种并发症,肝硬化腹水程度相对较高,会直接影响预后效果,而在对患者进行治疗时补钠治疗方法更具应用优势,可以改善患者预后,降低并发症发生率提高,缓解肝硬化腹水问题。

Objective:To investigate the clinical treatment and effect of cirrhosis ascites with hyponatremia.Method:A total of 56 patients with cirrhotic ascites complicated with hyponatremia from March 2017 to March 2018 were selected,they were randomly divided into the study group and the control group.Patients in the control group were treated with sodium restriction,while patients in the study group were treated with sodium supplementation.The total effective rate,the degree of ascites in cirrhosis and the incidence of complications were compared between the two groups.Result:The total effective rate of the study group was significantly higher than that of the control group,and the degree of ascites due to cirrhosis was significantly lower than that of the control group,and the incidence of complications was significantly lower than that of the control group(P<0.05).Conclusion:Cirrhotic ascites complicated with hyponatremia is prone to a variety of complications,cirrhotic ascites degree is relatively high,will directly affect the prognosis,and in the treatment of patients with sodium therapy has more application advantages,can improve the prognosis of patients,reduce the incidence of complications,alleviate the problem of cirrhotic ascites.